A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

被引：0

作者：

Jimenez-Vicente, Carlos ^{[1
]}

Garrote, Marta ^{[2
,3
,7
]}

Lopez-Guerra, Monica ^{[2
,3
,4
]}

Villamon, Eva ^{[5
]}

Guijarro, Francesca ^{[2
,3
]}

Perez-Valencia, Amanda Isabel ^{[1
]}

Martinez-Roca, Alexandra ^{[1
,2
]}

Balaguer, Olga ^{[6
]}

Alvarez-Larran, Alberto ^{[1
,3
]}

Hernandez-Boluda, Juan Carlos ^{[5
]}

Rovira, Montserrat ^{[1
,3
]}

Colomer, Dolors ^{[2
,3
]}

Diaz-Beya, Marina ^{[1
,2
,3
]}

Rozman, Maria ^{[2
]}

Esteve, Jordi ^{[1
,3
]}

机构：

[1] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain

[2] Hosp Clin Barcelona, Pathol Dept, Hematopathol Unit, Barcelona, Spain

[3] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain

[4] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

[5] Univ Valencia, Hosp Clin Univ INCLIVA, Valencia, Spain

[6] Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain

[7] Hosp Clin Barcelona, Pathol Dept, Hematopathol Unit, Villarroel 170, Barcelona 08036, Spain

来源：

LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 03期

关键词：

TRANSLOCATIONS;

D O I：

10.1080/10428194.2023.2295788

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：394 / 398

页数：5

共 50 条

[1] Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor
Verstovsek, S.
Subbiah, V.
Masarova, L.
Yin, C. Cameron
Tang, G.
Manshouri, T.
Asatiani, E.
Daver, N. G.
ANNALS OF ONCOLOGY, 2018, 29 (08) : 1880 - 1882
[2] Myeloid/lymphoid neoplasm with FGFR1 rearrangement
Germans, Sharon Koorse
Chen, Mingyi
BLOOD, 2021, 138 (10) : 912 - 912
[3] A Novel Fusion Partner in a Case of Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement
Chakraborty, S. R.
Ibrahim, S.
Johari, V.
Hunt, J.
Freeman, J.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S107 - S108
[4] Myeloid/lymphoid neoplasms with FGFR1 rearrangement
Strati, Paolo
Tang, Guilin
Duose, Dzifa Y.
Mallampati, Saradhi
Luthra, Rajyalakshmi
Patel, Keyur P.
Hussaini, Mohammad
Mirza, Abu-Sayeef
Komrokji, Rami S.
Oh, Stephen
Mascarenhas, John
Najfeld, Vesna
Subbiah, Vivek
Kantarjian, Hagop
Garcia-Manero, Guillermo
Verstovsek, Srdan
Daver, Naval
LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1672 - 1676
[5] Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement
Yan, Yiru
Qu, Shiqiang
Liu, Jinqin
Li, Chengwen
Yan, Xiao
Xu, Zefeng
Qin, Tiejun
Jia, Yujiao
Pan, Lijuan
Gao, Qingyan
Jiao, Meng
Li, Bing
Gale, Robert Peter
Xiao, Zhijian
LEUKEMIA & LYMPHOMA, 2023,
[6] Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement
Freyer, Craig W.
Hughes, Mitchell E.
Carulli, Alison
Bagg, Adam
Hexner, Elizabeth
EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 351 - 359
[7] Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying RUNX1 and NOTCH1 Gene Mutations
Wang, Xiaoxue
Huang, Xinyue
Pang, Hui
Xiao, Sheng
Gu, Hongcang
Zhang, Heyang
Wang, Baixun
Zhang, Lijun
Yan, Xiaojing
FRONTIERS IN ONCOLOGY, 2019, 9
[8] The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
Demiroglu, A
Steer, EJ
Heath, C
Taylor, K
Bentley, M
Allen, SL
Koduru, P
Brody, JP
Hawson, G
Rodwell, R
Doody, ML
Carnicero, F
Reiter, A
Goldman, JM
Melo, JV
Cross, NCP
BLOOD, 2001, 98 (13) : 3778 - 3783
[9] From the eosinophil to a novel FGFR1 fusion gene
Harper, Kirsteen
Horne, Gillian
Leach, Mike
Bain, Barbara J.
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1595 - 1596
[10] The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: Transforming activity and specific inhibition of FGFR1 fusion proteins.
Steer, EJ
Demiroglu, A
Heath, C
Pourgourides, E
Taylor, K
Bentley, M
Allen, SL
Koduru, P
Brody, JP
Hawson, G
Rodwell, R
Doody, ML
Carnicero, F
Reiter, A
Goldman, JM
Melo, JV
Cross, NCP
BLOOD, 2001, 98 (11) : 468A - 468A

← 1 2 3 4 5 →